BMY - Bristol Myers Opdivo injectable accepted for EU review
2024-06-21 07:25:03 ET
More on Bristol-Myers Squibb
- Bristol-Myers Squibb: Move Investing Time Horizon To 2025, At Least
- Bristol-Myers Squibb: Could This Be A Value Trap? (Technical Analysis)
- Bristol-Myers Squibb Company (BMY) Goldman Sachs 45th Annual Global Healthcare Conference
- EU to require additional cancer risk labeling on CAR T therapies
- Bristol Myers gets FDA approval for Augtyro for NTRK-positive cancers